Nasdaq · CIK 0001401914
DARE Dare Bioscience, Inc.
Insider trading from SEC Form 4. Last filing Feb 20, 2026.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at Dare Bioscience, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 12 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Sabrina Martucci Johnson Chef Executive Officer | AGrant or award Series A Convertible Preferred Stockderivative | +10,800 | - | - | 10,800 | Feb 20, 2026 |
| Feb 18, 2026 | Sabrina Martucci Johnson Chef Executive Officer | AGrant or award Common Stock Warrant (right to buy)derivative | +21,600 | - | - | 21,600 | Feb 20, 2026 |
| Jan 30, 2026 | Sabrina Martucci Johnson Chef Executive Officer | AGrant or award Employee Stock Option (right to buy)derivative | +172,000 | $0.00 | $0 | 172,000 | Feb 2, 2026 |
| Jan 30, 2026 | MarDee Haring-Layton Chief Accounting Officer | AGrant or award Employee Stock Option (right to buy)derivative | +49,000 | $0.00 | $0 | 49,000 | Feb 2, 2026 |
| Sep 4, 2025 | MarDee Haring-Layton Chief Accounting Officer | AGrant or award Employee Stock Option (right to buy)derivative | +57,000 | $0.00 | $0 | 57,000 | Sep 4, 2025 |
| Jul 9, 2025 | Susan L. Kelley director | AGrant or award Stock Option (right to buy)derivative | +4,500 | $0.00 | $0 | 4,500 | Jul 10, 2025 |
| Jul 9, 2025 | Jessica D. Grossman director | AGrant or award Stock Option (right to buy)derivative | +4,500 | $0.00 | $0 | 4,500 | Jul 10, 2025 |
| Jul 9, 2025 | Gregory W Matz director | AGrant or award Stock Option (right to buy)derivative | +4,500 | $0.00 | $0 | 4,500 | Jul 10, 2025 |
| Jul 9, 2025 | Robin Joan Steele director | AGrant or award Stock Option (right to buy)derivative | +4,500 | $0.00 | $0 | 4,500 | Jul 10, 2025 |
| Jul 9, 2025 | William H Rastetter director | AGrant or award Stock Option (right to buy)derivative | +4,500 | $0.00 | $0 | 4,500 | Jul 10, 2025 |
| Jan 28, 2025 | Sabrina Martucci Johnson Chef Executive Officer | AGrant or award Employee Stock Option (right to buy)derivative | +107,000 | $0.00 | $0 | 107,000 | Jan 31, 2025 |
| Jan 28, 2025 | MarDee Haring-Layton Chief Accounting Officer | AGrant or award Employee Stock Option (right to buy)derivative | +38,000 | $0.00 | $0 | 38,000 | Jan 31, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Jessica D. Grossmandirector
- MarDee Haring-LaytonChief Accounting Officer
- Sabrina Martucci JohnsonChef Executive Officer
- Susan L. Kelleydirector
- Gregory W Matzdirector
- William H Rastetterdirector
- Robin Joan Steeledirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.